New Jersey Better Educational Savings Trust’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-1,000
Closed -$233K 116
2019
Q3
$233K Hold
1,000
0.33% 118
2019
Q2
$234K Buy
+1,000
New +$231K 0.31% 127
2019
Q1
Sell
-3,425
Closed -$603K 171
2018
Q4
$603K Buy
+3,425
New +$1.09M 0.77% 25
2018
Q3
Sell
-1,800
Closed -$522K 183
2018
Q2
$522K Sell
1,800
-400
-18% -$112K 0.57% 47
2018
Q1
$602K Buy
2,200
+400
+22% +$124K 0.67% 38
2017
Q4
$573K Sell
1,800
-400
-18% -$128K 0.58% 54
2017
Q3
$689K Sell
2,200
-800
-27% -$237K 0.58% 48
2017
Q2
$814K Buy
+3,000
New +$793K 0.71% 29
2015
Q4
Sell
-3,100
Closed -$905K 180
2015
Q3
$905K Buy
3,100
+100
+3% +$33K 0.65% 44
2015
Q2
$1.21M Sell
3,000
-600
-17% -$241K 0.79% 26
2015
Q1
$1.52M Sell
3,600
-600
-14% -$236K 0.67% 29
2014
Q4
$1.43M Buy
4,200
+600
+17% +$194K 0.64% 35
2014
Q3
$1.19M Buy
+3,600
New +$1.19M 0.55% 43

Other funds holding BIIB

New Jersey Better Educational Savings Trust's BIIB Position: Q4 2019 in Review

New Jersey Better Educational Savings Trust sold out of Biogen (BIIB) in Q4 2019, closing a stake of 1,000 shares — an estimated $233K sold.

New Jersey Better Educational Savings Trust first reported a position in BIIB in Q3 2014 and held it in 13 quarters. The position peaked at $1.52M in Q1 2015. 1,103 funds tracked by Wall St. Rank hold BIIB as of Q4 2019.

  • New Jersey Better Educational Savings Trust reported no remaining Biogen position as of Q4 2019 after selling out during the quarter.
  • New Jersey Better Educational Savings Trust sold 1,000 Biogen shares in Q4 2019, an estimated $233K.
  • New Jersey Better Educational Savings Trust first reported a position in Biogen in Q3 2014 and held it in 13 quarters.
  • New Jersey Better Educational Savings Trust's Biogen position peaked at $1.52M in Q1 2015.
  • 1,103 funds tracked by Wall St. Rank held Biogen as of Q4 2019.

Based on New Jersey Better Educational Savings Trust's 13F filing for Q4 2019, filed 31 Jan 2020.